Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Cohort profile: The MULTI sTUdy Diabetes rEsearch (MULTITUDE) consortium.

Pino EC, Zuo Y, Maciel De Olivera C, Mahalingaiah S, Keiser O, Moore LL, Li F, Vasan RS, Corkey BE, Kalesan B.

BMJ Open. 2018 May 5;8(5):e020640. doi: 10.1136/bmjopen-2017-020640.

2.

Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].

LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep.

3.

Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004-2014.

Mathur R, Bhaskaran K, Edwards E, Lee H, Chaturvedi N, Smeeth L, Douglas I.

BMJ Open. 2017 Feb 28;7(2):e014444. doi: 10.1136/bmjopen-2016-014444.

4.

Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.

Wang SY, Andrews CA, Herman WH, Gardner TW, Stein JD.

Ophthalmology. 2017 Apr;124(4):424-430. doi: 10.1016/j.ophtha.2016.10.031. Epub 2016 Nov 30.

6.

Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case-control analysis.

Owusu Adjah ES, Bellary S, Hanif W, Patel K, Khunti K, Paul SK.

Cardiovasc Diabetol. 2018 May 15;17(1):70. doi: 10.1186/s12933-018-0712-1.

7.

Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.

Yeaw J, Halinan S, Hines D, Delozier A, Perez M, Boye M, Boye KS, Blanchette CM.

Appl Health Econ Health Policy. 2014 Apr;12(2):219-30. doi: 10.1007/s40258-014-0086-9.

PMID:
24573912
8.

Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis.

Weng W, Liang Y, Kimball ES, Hobbs T, Kong S, Sakurada B, Bouchard J.

J Med Econ. 2016 Jul;19(7):655-62. doi: 10.3111/13696998.2016.1151795. Epub 2016 Feb 26.

PMID:
26855139
10.

Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth.

Imperatore G, Boyle JP, Thompson TJ, Case D, Dabelea D, Hamman RF, Lawrence JM, Liese AD, Liu LL, Mayer-Davis EJ, Rodriguez BL, Standiford D; SEARCH for Diabetes in Youth Study Group.

Diabetes Care. 2012 Dec;35(12):2515-20. doi: 10.2337/dc12-0669.

11.

Comorbidity network for chronic disease: A novel approach to understand type 2 diabetes progression.

Khan A, Uddin S, Srinivasan U.

Int J Med Inform. 2018 Jul;115:1-9. doi: 10.1016/j.ijmedinf.2018.04.001. Epub 2018 Apr 9.

PMID:
29779710
12.

Longitudinal Associations Between Neighborhood Physical and Social Environments and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).

Christine PJ, Auchincloss AH, Bertoni AG, Carnethon MR, Sánchez BN, Moore K, Adar SD, Horwich TB, Watson KE, Diez Roux AV.

JAMA Intern Med. 2015 Aug;175(8):1311-20. doi: 10.1001/jamainternmed.2015.2691.

13.

Association of type 2 diabetes with in-hospital complications among women undergoing breast cancer surgical procedures. A retrospective study using the Spanish National Hospital Discharge Database, 2013-2014.

Lopez-de-Andres A, Jimenez-Trujillo I, Hernandez-Barrera V, de Miguel-Diez J, Mendez-Bailon M, de Miguel-Yanes JM, Perez-Farinos N, Salinero-Fort MA, Del Barrio JL, Romero-Maroto M, Jimenez-Garcia R.

BMJ Open. 2017 Nov 8;7(11):e017676. doi: 10.1136/bmjopen-2017-017676.

14.

Insulin-sensitive adiposity is associated with a relatively lower risk of diabetes than insulin-resistant adiposity: the Bogalusa Heart Study.

Zhang T, Li Y, Zhang H, Sun D, Li S, Fernandez C, Harville E, Bazzano L, He J, Chen W.

Endocrine. 2016 Oct;54(1):93-100. Epub 2016 Apr 8.

PMID:
27060004
15.

Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design.

Zghebi SS, Rutter MK, Ashcroft DM, Salisbury C, Mallen C, Chew-Graham CA, Reeves D, van Marwijk H, Qureshi N, Weng S, Peek N, Planner C, Nowakowska M, Mamas M, Kontopantelis E.

BMJ Open. 2018 Jun 30;8(6):e020926. doi: 10.1136/bmjopen-2017-020926.

16.

Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK.

McGovern A, Hinton W, Correa A, Munro N, Whyte M, de Lusignan S.

BMJ Open. 2016 Nov 24;6(11):e012801. doi: 10.1136/bmjopen-2016-012801.

17.

Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance.

Boehme MW, Buechele G, Frankenhauser-Mannuss J, Mueller J, Lump D, Boehm BO, Rothenbacher D.

BMC Public Health. 2015 Sep 3;15:855. doi: 10.1186/s12889-015-2188-1.

18.

Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.

Garg A, Birabaharan M, Strunk A.

J Am Acad Dermatol. 2018 Jul;79(1):71-76. doi: 10.1016/j.jaad.2018.01.014. Epub 2018 Jan 12.

PMID:
29339240
19.

Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study.

Martinez-Laguna D, Nogues X, Abrahamsen B, Reyes C, Carbonell-Abella C, Diez-Perez A, Prieto-Alhambra D.

Osteoporos Int. 2017 Sep;28(9):2573-2581. doi: 10.1007/s00198-017-4096-y. Epub 2017 Jul 25.

PMID:
28744600
20.

Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Smith N, Webber E, Perdue LA, Bigler KD, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec.

Supplemental Content

Support Center